BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/18/2026 5:45:19 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 119006
Country China
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Chronic ulcer diagnosis and perforation risk with oral agent contrast-enhanced ultrasound: A case report and review of literature
Manuscript Source Unsolicited Manuscript
All Author List Man-Li Wei and Qing-Lan Tan
Funding Agency and Grant Number
Funding Agency Grant Number
Youth Fund for Self-Financed Scientific Research Projects of the Guangxi Zhuang Autonomous Region Health Commission Z20190921
Corresponding Author Man-Li Wei, Associate Chief Physician, Department of Ultrasound Medicine, The First People's Hospital of Nanning, No. 89, Qixing Road, Qingxiu District, Nanning 530021, Guangxi Zhuang Autonomous Region, China. 260077529@qq.com
Key Words Gastric ulcer; Multidisciplinary treatment; Hepatocellular carcinoma; Oral agent; Ultrasound; Perforation; Case report
Core Tip Gastric perforation is a rare yet severe complication of abdominal radiotherapy, occurring more frequently when combined immunotherapy and tyrosine kinase inhibitor therapy are administered. Most patients require emergency surgical intervention. This study reports a case where, within the complex context of comprehensive hepatocellular carcinoma treatment (involving radiotherapy, chemotherapy, immunotherapy, and targeted therapy), traditional methods (gastroscopy, contrast-enhanced computed tomography) could not accurately assess ulcer infiltration depth due to blood crust coverage and gastric wall edema. Oral agent contrast-enhanced ultrasound as a novel monitoring tool, clearly demonstrated that the ulcer had reached the serosal layer, thereby successfully predicting impending perforation.
Citation Wei ML, Tan QL. Chronic ulcer diagnosis and perforation risk with oral agent contrast-enhanced ultrasound: A case report and review of literature. World J Gastroenterol 2026; In press
Received
2026-01-29 03:35
Peer-Review Started
2026-01-29 03:35
First Decision by Editorial Office Director
2026-02-13 08:20
Return for Revision
2026-02-13 08:20
Revised
2026-02-27 05:35
Publication Fee Transferred
2026-03-03 14:35
Second Decision by Editor
2026-03-18 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-03-18 05:45
Articles in Press
2026-03-18 05:45
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com